/
DRIO
$6.80-$0.23 (-3.27%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$51.4M
7M shares
52-week range
$5.84 – $17.74
8% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
3.84%
Moderate
Price (6 mo)
Loading chart…
Change$-420.40
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4M | $7.6M | $7.6M | $20.5M | $27.7M | $20.4M | $27.0M | $22.4M |
| Cost of revenue | $5.6M | $5.0M | $5.1M | $12.4M | $18.0M | $14.4M | $13.8M | $9.7M |
| Gross profit | $1.8M | $2.6M | $2.5M | $8.1M | $9.7M | $6.0M | $13.3M | $12.7M |
| Gross margin | 23.9% | 34.4% | 33.2% | 39.3% | 34.9% | 29.4% | 49.1% | 56.6% |
| R&D | $3.7M | $3.7M | $4.4M | $17.2M | $19.6M | $20.2M | $24.2M | $13.8M |
| Operating income | −$17.7M | −$17.7M | −$29.9M | −$76.5M | −$56.8M | −$56.2M | −$57.7M | −$36.7M |
| EBITDA | −$17.5M | −$17.5M | −$29.7M | −$70.0M | −$55.6M | −$54.4M | −$37.1M | −$34.7M |
| Net income | −$17.8M | −$17.7M | −$29.4M | −$76.8M | −$62.2M | −$59.4M | −$42.7M | −$41.7M |
| Net margin | -240.8% | -234.6% | -388.7% | -374.2% | -224.9% | -292.0% | -158.1% | -186.6% |
| EPS (diluted) | -15.21 | -7.84 | -5.55 | -4.63 | -2.63 | -1.93 | -0.74 | 1.24 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $26M | $-3.71 | $-3.83–$-3.53 | 2 |
| 2027 | $38M | $-1.94 | $-2.01–$-1.85 | 2 |
| 2028 | $53M | $-1.03 | $-1.52–$-0.55 | 2 |
| 2029 | $67M | $-0.40 | $-0.41–$-0.38 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
DarioHealth Corp. Common Stock
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
www.mydario.com- Employees
- 165
- IPO / List date
- Mar 8, 2013
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds DRIO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in DRIO as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-08-28 | 1-for-20reverse |
| 2019-11-18 | 1-for-20reverse |
| 2016-03-04 | 1-for-18reverse |
| 2014-10-06 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded DRIO yet.
